Anti-tumor activity of C-raf antisense—correction

被引：0
|
作者：
Brett P. Monia
机构：
[1] Director,
[2] Molecular Pharmacology,undefined
[3] Isis Pharmaceuticals,undefined
来源：
Nature Medicine | 1999年 / 5卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：127 / 127
相关论文
共 50 条
  • [1] Anti-tumor activity of C-raf antisense (vol 2, pg 668, 1996)
    Monia, BP
    NATURE MEDICINE, 1999, 5 (02) : 127 - 127
  • [2] Rheb inhibits C-Raf activity and B-Raf/C-Raf heterodimerization
    Karbowniczek, Magdalena
    Robertson, Gavin P.
    Henske, Elizabeth Petri
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (35) : 25447 - 25456
  • [3] C-raf antisense treatment enhances paclitaxel cytotoxicity in human tumor cells
    RasouliNia, A
    Liu, D
    Perdue, S
    Britten, RA
    CANCER GENE THERAPY, 1997, 4 (06) : P17 - P17
  • [4] Diacylglycerol Kinase η Augments C-Raf Activity and B-Raf/C-Raf Heterodimerization
    Yasuda, Satoshi
    Kai, Masahiro
    Imai, Shin-ichi
    Takeishi, Kazuki
    Taketomi, Akinobu
    Toyota, Minoru
    Kanoh, Hideo
    Sakane, Fumio
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (43) : 29559 - 29570
  • [5] Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase
    Monia, BP
    Johnston, JF
    Geiger, T
    Muller, M
    Fabbro, D
    NATURE MEDICINE, 1996, 2 (06) : 668 - 675
  • [6] Anti-tumor activity of CKBP002: A small molecule inhibitor of c-raf, Jaks and Stat3 signal pathway in pancreatic cancer
    Meng, Fan Yan
    Li, Qian
    Xie, Weidong
    CANCER RESEARCH, 2009, 69
  • [7] The Tumor Suppressor DiRas3 Forms a Complex with H-Ras and C-RAF Proteins and Regulates Localization, Dimerization, and Kinase Activity of C-RAF
    Baljuls, Angela
    Beck, Matthias
    Oenel, Ayla
    Robubi, Armin
    Kroschewski, Ruth
    Hekman, Mirko
    Rudel, Thomas
    Rapp, Ulf R.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (27) : 23128 - 23140
  • [8] In vivo pro-apoptotic and antitumor efficacy of a c-raf antisense phosphorothioate oligonucleotide:: Relationship to tumor size
    Lau, QC
    Achenbach, TV
    Borchers, O
    Müller, R
    Slater, EP
    ANTISENSE & NUCLEIC ACID DRUG DEVELOPMENT, 2002, 12 (01): : 11 - 20
  • [9] Selective inhibition of A-Raf and C-Raf mRNA expression by antisense oligodeoxynucleotides in rat vascular smooth muscle cells: Role of A-Raf and C-Raf in serum-induced proliferation
    Cioffi, CL
    Garay, M
    Johnston, JF
    McGraw, K
    Boggs, RT
    Hreniuk, D
    Monia, BP
    MOLECULAR PHARMACOLOGY, 1997, 51 (03) : 383 - 389
  • [10] Mutations of C-RAF are rare in human cancer because C-RAF has a low basal kinase activity compared with B-RAF
    Emuss, V
    Garnett, M
    Mason, C
    Marais, R
    CANCER RESEARCH, 2005, 65 (21) : 9719 - 9726
12345